Trials
3 active
3 in total · 2 in the EU
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “PM54 powder for concentrate for solution for infusion (3 mg/vial) is a sterile, preservative-free, lyophilized white to yellowish cake in a single-dose vial for reconstitution prior to intravenous infusion. Each vial contains 3 mg PM54. Route of administration: Intravenous infusion”In the company’s words, NCT05841563 on ClinicalTrials.gov
- Tested for
- Advanced Solid Tumor (2 trials), Advanced Malignancies
- Main trialPhase 1/2
- “The main purpose of the study is to evaluate the safety, tolerability and recommended dose of PM54 in combination with pembrolizumab. To assess the antitumor activity of PM54 in combination with pembrolizumab in terms of clinical benefit rate (CBR) and objective response rate (ORR) based on investigator's assessment in participants in other cohorts.”In the company’s words, NCT07644039 on ClinicalTrials.gov
Other drugs for Advanced Solid Tumor
- AvelumabEMD Serono Research & Development Institute, Inc. · Phase 3
- AlectinibRoche · Phase 3
- AtezolizumabRoche · Phase 3
- AU-011Aura Biosciences · Phase 3
- BevacizumabRoche · Phase 3
- CadonilimabAkeso · Phase 3
Coming up3
- 30 DecPhase 1 trial completes · ClinicalTrials.gov
- 2 Apr 2029Phase 1/2 trial completes · ClinicalTrials.gov
- 27 Sep 2029Phase 1/2 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1/2Recruiting | 2 Apr 2029 | Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies | |
| Phase 1/2Not yet recruiting | 27 Sep 2029 | Study of PM54 in Combination With Cytotoxic and Targeted Agents in Adult Participants With Advanced Malignancies | |
| Phase 1Recruiting | 30 Dec 2026 | Clinical Trial of PM54 in Advanced Solid Tumors Patients. |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026